‘What happens when the wind doesn’t blow or the sun doesn’t shine?’ read more
The Science Media Centre is not restricted to reacting to the headlines, and has helped scientists to more proactively set the agenda by bringing new science or evidence to journalists. This comes from our regular briefings, which take a variety of forms and cover a wide range of topics. Many are background briefings introducing journalists to the best experts and science on controversial issues like nuclear waste, nanotechnology, emerging diseases, or animal research, for example. They may also be news briefings where the SMC works with scientists to give the national media a new story on developments within science, whether it’s a report on climate change, a paper on stem cells being published in a leading journal, or science funding cuts in the latest budget. In addition, the SMC encourages leading experts to ‘speak out’ to the media about developments they believe may pose a threat to scientific research – not something science has been renowned for.
‘What happens when the wind doesn’t blow or the sun doesn’t shine?’ read more
The UK has been considering following in the footsteps of the US and Australia by introducing mental health screening of military personnel after they return from deployment. However, there have been question marks over whether screening works, whether it the best way of helping military personnel and whether it is worth the money. read more
The effect of vitamin D supplementation on health continues to be a subject of controversy, despite recent recommendations from SACN and PHE that everyone over the age of one should consume 10 micrograms of vitamin D daily to ensure good health. read more
Boxing and American football are under scrutiny because of head injuries causing long-term damage to the brain, but the situation is much less clear for football where heading is extremely common, but head injuries are less so. read more
There is broad agreement that e-cigarettes are much less dangerous than tobacco but data on their actual health effects in humans are sparse. read more
Acrylamide is a chemical that is created naturally when many foods, particularly starchy foods like potatoes and bread, are cooked for long periods at high temperatures, such as when baking, frying, grilling, toasting and roasting. read more
Future dangers of antimicrobial resistance are widely acknowledged, with farming practices often blamed for the rise in resistance to common antibiotics in human diseases. read more
Donald Trump has said that no-one really knows whether climate change is real. Scientists tend to disagree. But what will the new presidency have in store for the US approach to climate change? read more
Two leading marine biologists, Prof Daniel Pauly and Dr Dirk Zeller from the University of British Columbia’s Sea Around Us project, published findings last year that challenged fundamental assumptions about global fisheries. read more
Antidepressants are a constant source of controversy. Concerns are raised that these drugs are not safe, that the side-effects are being overlooked, that they are being over-prescribed and are part of a trend of over-medicalisation. read more
Last week we heard details of the government’s tiered levy on sugary drinks, which was broadly welcomed by experts. read more
Following the failure of the recent solanezumab trial the question now is where does Alzheimer’s research go from here? We have brought together four top experts to discuss:
Is the solanezumab trial a complete failure? Can we learn anything from it?
Is this the end for the amyloid hypothesis? Could we be going about this all wrong? Is Tau the answer?
What other drugs are in the pipeline? Do the solanezumab results lower our hopes for their success?
Are there other non-drug therapies on the horizon that might offer success?
Will we not progress until we get better at detecting and diagnosing this disease?
Do we think we will ever find a treatment? Is our only hope to reduce lifestyle risks as much as possible? read more
Air pollution has been in and out of the headlines recently due to the diesel emissions scandal and proposed Heathrow airport expansion. We’ve heard that the UK has been exceeding EU limits for nitrogen oxide emissions, and we’ve heard estimates of the numbers of people in the UK whose deaths are partly attributable to particulate air pollution.
NICE are publishing a draft guideline on road-traffic-related air pollution. The guideline aims to improve air quality and therefore prevent illnesses and deaths related to air pollution. The draft guideline will outline recommendations to government and local authorities.
After Parliament voted overwhelmingly in favour of allowing mitochondrial donation last year the UK regulatory process for this new treatment has moved on. The Newcastle based scientists ready to offer the treatment have answered more of the scientific questions raised and the HFEA commissioned a fourth independent science panel to review this and other research. Meanwhile stories emerge of babies being born around the world with the same technique but under very different regulatory oversight.
Now this incredible treatment takes a very significant step closer to the clinic as the science review panel delivers its fourth and possibly final report on the state of the science and makes recommendations as to whether it is safe and effective in order to proceed to treating patients.
The pollsters got it wrong in the general election, the Brexit vote and now the US election leading some commentators to declare election polls as dead. So what is going on? Did the polls get it wrong because of innate weaknesses in polling or is something else going on here that can’t be fixed by pollsters? Is polling finished or can it be reformed for a new world? What, if anything, would society lose if we say goodbye to poll. read more
The UK energy system is going through a period of rapid change. The implications of the vote to leave the EU and subsequent changes within government are largely unknown. Uncertainties about the future of the energy system were already high; these changes have compounded them. The UK Energy Research Centre has produced an evidence-based commentary – addressing heat, transport, electricity, gas, and other major components of the energy system – which aims to take stock of UK energy policy ahead of the Autumn Statement, the Industrial Strategy and the Emissions Reduction Plan, and make recommendations for action by government. read more
Scientists from Rothamsted Research, the University of Essex and Lancaster University provided an update on a new research project with GM wheat plants that have been engineered to carry out photosynthesis more efficiently. This trait has the potential for increased yields. read more
This time last year, climate scientists came to the SMC to brief journalists ahead of the Paris negotiations. As the next COP meeting in Marrakesh approaches, those same scientists talked about the latest in climate science. What do the most recent observations show and has anything significantly changed? What trajectory are we on, and is the policy response in step with the science? What are scientists expecting to happen to temperatures and the earth’s response to greenhouse gases? And are we moving fast enough with clean energy technologies? read more
In England up to two in 100 children have Chronic Fatigue Syndrome (CFS/ME), the illness means they are unable to go to school or do other activities for more than three months. In fact 1% of secondary school children miss a day a week or more because of it. Unfortunately controversy rages around the illness and the treatment. Most children will recover if they receive specialist treatment; however, there is very limited specialist care in the UK and approximately 90% of children live too far away to receive the treatment they need. Cognitive Behavioural Therapy (CBT) is known to be effective for children and a very successful trial in the Netherlands showed it can be delivered over the internet, meaning children can be helped wherever they live. However, we do not know if the results can be replicated in the UK so researchers, amidst rising tension from some people who do not support treatments such as CBT or Graded Exercise Therapy, are now starting a large clinical trial to test whether this treatment would work in the UK and should be available on the NHS. read more
Autism is a severe developmental disorder that affects 1 in 100 children. The core difficulties in social communication, which can mean children not even being able to communicate verbally, and the rigid and repetitive behaviours usually have a profound effect on development into adulthood and result in estimated £1-1.5 million lifetime societal costs per child. Despite many claims and previous research, there has to date been no treatment for the condition that has succeeded in improving these core developmental symptoms over the long-term. Now, however, researchers are reporting the long-term results of an intervention with families early in development that may begin to change our expectations. read more